Tag: conflict of interest

Blog Posts (6)

May 26, 2009

Dr. Hamburg, Divest Thyself

One of the wealthiest of the Obama administration appointees, Dr. Margaret Hamburg, has to offload her stock pretty quickly–apparently that’s what comes from being married to a very successful hedge fund manager and holding a wide range of health and other medical related stock, says the Wall Street Journal.…

April 2, 2009

First Cleveland Clinic, Then Penn, Now Stanford...

As we reported on our blog a few weeks ago, it wouldn’t be long before many medical institutions were jumping on the conflict of interest bandwagon.…

January 26, 2009

Spine Transparency

The North American Spine Society has announced that researchers must disclose not only that they receive money from medical device makers but also the sum of those consulting fees, reports the Wall Street Journal.…

December 8, 2008

Jumping on the Conflict of Interest Bandwagon

After the Cleveland Clinic announced last week that it would disclose all of its physician’s financial relationships with pharmaceutical companies, other hospitals are following suit as not to be left behind on the ethics bandwagon.…

October 14, 2008

Something to Declare...But No One Cares

Disclosing financial conflicts of interest to potential research subjects does not effect their willingness to participate in research, found a recent Johns Hopkins, Duke, and Wake Forest University study.…

March 30, 2008

The joints where industry and orthopedists meet

Scott Haig, an orthopedist, writing in Time about the conflicts of interest that surfaced at the recent annual meeting of the American Academy of Orthopaedic Surgeons:

The DOJ’s slap was felt acutely by everyone at the convention.

Published Articles (7)

American Journal of Bioethics: Volume 11 Issue 1 - Jan 2011

Clarifying Conflict of Interest Howard Brody

American Journal of Bioethics: Volume 11 Issue 1 - Jan 2011

Responses to Peer Commentaries on ?Clarifying Conflict of Interest? Howard Brody

American Journal of Bioethics: Volume 11 Issue 1 - Jan 2011

Beyond a Pejorative Understanding of Conflict of Interest Bryn Williams-Jones

American Journal of Bioethics: Volume 8 Issue 8 - Aug 2008

Conflicts of Interest in Bioethics: A Response to Our Critics David C. Landy

American Journal of Bioethics: Volume 8 Issue 8 - Aug 2008

Who Is Buying Bioethics Research? Richard R. Sharp

American Journal of Bioethics: Volume 5 Issue 1 - Jan 2005

Lessons in Conflict of Interest: The Construction of the Martyrdom of David Healy and The Dilemma of Bioethics James Coyne

American Journal of Bioethics: Volume 2 Issue 3 - Sep 2002

Conflict of Interest and The American Journal of Bioethics Kelly A. Carroll

News (12)

April 30, 2013 12:39 pm

Did Novartis Violate Its Corporate Integrity Agreement?

Twice this past week, the US Department of Justice filed lawsuits alleging Novartis paid kickbacks to boost prescriptions and caused federal healthcare programs to pay for medicines based on false claims.

April 9, 2013 4:14 pm

Marijuana: Shane Cohn Says Police Sergeant's Pro-Reform Lobbying is a Conflict of Interest

St. Louis Police Sergeant is suing his department, alleging that officials have tried to suppress his free-speech by blocking his pro-marijuana reform lobbying.

April 9, 2013 4:11 pm

Majority of U.S. Medical Schools Have Strong Pharmaceutical Conflict-of-Interest Policies

While only four medical schools ban sales representatives from campus, the majority of U.S. medical schools have implemented strong conflict-of-interest policies this year, according to the 2013 American Medical Student Association (AMSA) PharmFree Scorecard.

March 7, 2013 2:56 pm

Texas Sex Ed Bill Seeks To Block Planned Parenthood Over 'Conflict Of Interest' As Abortion Provider

Planned Parenthood is unfit to provide sex education materials to Texas students because the organization’s status as an abortion provider constitutes a “conflict of interest,” advocates of a state bill argued on Tuesday.

March 1, 2013 12:43 pm

Study authors: On medical school conflict of interest policies, more enforcement needed (Boston.com)

Students at Brown University’s Alpert Medical School are prohibited from accepting gifts or meals from pharmaceutical companies and drug salespeople. Yet, when she was training in a primary care clinic, student Reshma Ramachandran said drug salespeople stopped by often bringing lunch for the staff.
February 4, 2013 1:18 pm

Physician Payment Sunshine Act (Policy Med)

The Physician Payment Sunshine Act final rule was released this past week.  The final regulations will greatly affect the entire pharmaceutical and medical device industry and applies to manufacturers of drugs, devices, biologicals, or medical supplies to report annually to the Secretary of HHS.

January 1, 2013 7:29 pm

Rising painkiller addiction shows damage from drugmakers’ role in shaping medical opinion (The Washington Post)

An article about a conflict of interest between drug companies, the studies they fund and the abundance of painkiller prescriptions.

November 30, 2012 2:30 pm

Doctors Who Advise Wall Street Investors Operate In Ethical Grey Zone (Huffington Post)

According to allegations made in a recent $276 million insider trading fraud lawsuit, an enterprising trader looking for a nugget of inside information can hire an “expert network” company to offer their services to money managers.  But federal authorities have said the relationships can be conduits to fraud.

November 26, 2012 5:34 pm

As drug industry’s influence over research grows, so does the potential for bias (Washington Post)

Over a year-long period ending in August, NEJM published 73 articles on original studies of new drugs.  Of those articles, 60 were funded by a pharmaceutical company and 50 were co-written by drug company employees.

October 19, 2012 6:51 pm

Research Firm Reaped Stem Cell Funds Despite Panel's Advice (LA Times)

StemCells Inc. has had rather a charmed relationship with California’s publicly funded stem cell program, with some $40 million in awards approved this year.  Co-founded by an eminent Stanford research scientist, the firm ranks first among all corporate recipients of approved funding from CIRM, despite only collecting about $1 million a year from licensing patents and selling cell cultures.

View More News Items